seventy-four patients with non-small cell lung cancer were treated in a prospective , randomized trial either with a four-drug combination of cisplatin , doxorubicin , cyclophosphamide , and vindesine ( pace ) or with a three-drug combination of cisplatin , cyclophosphamide , and vindesine ( pce ) .
C0008838
cisplatin
C0246101
pce